نتائج البحث
عرض كل النتائج
Boycat Boycat Boycat
الرئيسية
المجموعات
الصفحات
سوق المنتجات
شاهد المزيد
المجموعات الصفحات سوق المنتجات المناسبات المدونات التمويل مفاوضاتي Courses
انضم إلينا
تسجيل الدخول تسجيل
الوضع المظلم
البحث
المنشورات
المدونات
المستخدمون
الصفحات
المجموعات
المناسبات
  • Ates Karahan @ateskarhan أضاف وظيفة جديدة in Health
    2026-05-27 06:24:47 · ترجمة ·
    Oncology Biosimilar Monoclonal Antibodies market Research Report by End User & Industry Vertical
    "Oncology Biosimilar Monoclonal Antibodies Market Summary: According to the latest report published by Data Bridge Market Research, the Oncology Biosimilar Monoclonal Antibodies Market The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period A...
    0 التعليقات ·0 المشاركات ·209 مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • Kajal Khomane @Kajal أضاف وظيفة جديدة in أخرى
    2026-05-27 11:41:03 · ترجمة ·
    Biosimilar market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
    " According to the latest report published by Data Bridge Market Research, the Biosimilar Market The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the...
    0 التعليقات ·0 المشاركات ·251 مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • Prasad Shinde @prasadshinde أضاف وظيفة جديدة in Health
    2026-03-02 17:28:47 · ترجمة ·
    Bone Health Innovation: Competitive Landscape and Biosimilar Entry in the Denosumab Market
    "Detailed Analysis of Executive Summary Denosumab Market Size and Share Data Bridge Market Research analyses that the global denosumab market which was USD 2,892.17 million in 2022, would rocket up to USD 7,109.92 million by 2030, and is expected to undergo a CAGR of 11.9% during the forecast period.  With this Denosumab Market report, businesses can get details about market...
    0 التعليقات ·0 المشاركات ·1كيلو بايت مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • James Beck @James أضاف وظيفة جديدة in Networking
    2026-02-16 12:40:07 · ترجمة ·
    Oncology Biosimilar Monoclonal Antibodies Market Trends: Growth, Share, Value, Size, and Analysis By 2033
    "Executive Summary Oncology Biosimilar Monoclonal Antibodies Market Research: Share and Size Intelligence The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period. The credible Oncology Biosimilar Monoclonal...
    0 التعليقات ·0 المشاركات ·2كيلو بايت مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • Vanshika Swami @Vanshika04 أضاف وظيفة جديدة in Health
    2026-03-13 05:47:49 · ترجمة ·
    Biologics and Biosimilars Market by 2031 – Trends, Market News, and Recent Developments
    The biologics and biosimilars market is witnessing remarkable growth globally, driven by increasing prevalence of chronic and life-threatening diseases, rapid technological advancements, and growing adoption of cost-effective therapies. Biologics, derived from living organisms, have transformed the treatment landscape for conditions like cancer, autoimmune disorders, and infectious diseases....
    0 التعليقات ·0 المشاركات ·2كيلو بايت مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • Vanshika Swami @Vanshika04 أضاف وظيفة جديدة in Health
    2026-04-23 10:41:21 · ترجمة ·
    Global Oncology Biosimilars Market Forecast to 2031: Growth Trends and Regional Share Analysis
    The global oncology biosimilars market is witnessing rapid expansion, driven by the increasing prevalence of cancer and the rising demand for cost-effective biologic therapies. Biosimilars, which are highly similar to reference biologic drugs, offer significant cost advantages while maintaining comparable safety and efficacy profiles. As healthcare systems worldwide face growing financial...
    0 التعليقات ·0 المشاركات ·1كيلو بايت مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
  • Prasad Shinde @prasadshinde أضاف وظيفة جديدة in Dance
    2026-03-19 09:44:43 · ترجمة ·
    The Biologic Pivot: How Adalimumab Biosimilars are Redefining 2026 Market Access and Patient Affordability
    "Latest Insights on Executive Summary Adalimumab Biosimilar Market Market Share and Size Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The market insights gained through this keyword market research analysis...
    0 التعليقات ·0 المشاركات ·1كيلو بايت مشاهدة ·0 معاينة
    الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
© 2026 Boycat
Arabic
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
الشروط الخصوصية Boycat Community اتصل بنا الدليل المطوريين